 long-term evalu indobufen peripher vascular diseas indobufen inhibitor platelet aggreg patient intermitt claudic due peripher vascular diseas patient year patient indobufen asa control group patient treatment author mean treadmil exercis test pain-fre walk distanc pfwd global walk distanc gwd recoveri time exercis treatment period patient claudic claudic diabet short pfwd gwd indobufen effect asa pfwd gwd group side effect indobufen cardiac morbid mortal conclus indobufen activ safeti chronic treatment patient peripher diseas long period side effect